This company has been marked as potentially delisted and may not be actively trading. NASDAQ:CSII Cardiovascular Systems (CSII) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cardiovascular Systems Stock (NASDAQ:CSII) 30 days 90 days 365 days Advanced Chart Get Cardiovascular Systems alerts:Sign Up Key Stats Today's Range$20.00▼$20.0050-Day Range$19.87▼$20.0052-Week Range$12.26▼$20.57Volume4,300 shsAverage Volume765,906 shsMarket Capitalization$843.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN. Read More Receive CSII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardiovascular Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address CSII Stock News HeadlinesResearch shows how trained immunity links to cardiovascular diseaseNovember 8, 2024 | msn.comLarge-scale genetic study identifies targets that could reduce cardiovascular risk by modulating blood metabolitesOctober 29, 2024 | msn.comAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and searches — are feeding the next wave of AI innovation. Big Tech is harvesting it. Mode Mobile is giving it back to you. They are creating a user-powered data economy that shares the upside, and +50M users have already generated +$325M in earnings. This isn't a theory… Mode’s 32,481% revenue growth from 2019-2022 landed them the #1 spot on Deloitte’s 2023 list of fastest growing companies in software, and they’ve secured the Nasdaq ticker $MODE ahead of a potential IPO. The offering could close any moment now. AI breakthroughs are everywhere, but these models need your data to survive. Invest in the company that allows you to share in the profits from yours.July 28 at 2:00 AM | Mode Mobile (Ad)Migraines linked to healthy vascular system despite cardiovascular risk factorsOctober 23, 2024 | msn.comCardiovascular scientists identify potential new treatment for failing heartsOctober 17, 2024 | msn.comRisk for Most Cardiovascular Events Reduced After COVID-19 VaccinationOctober 17, 2024 | msn.comStanding more may not reduce cardiovascular disease risk, could increase circulatory issuesOctober 17, 2024 | msn.comNew nanotherapy targets artery inflammation in cardiovascular diseaseOctober 11, 2024 | msn.comSee More Headlines CSII Stock Analysis - Frequently Asked Questions How were Cardiovascular Systems' earnings last quarter? Cardiovascular Systems, Inc. (NASDAQ:CSII) issued its quarterly earnings results on Wednesday, February, 8th. The medical device company reported ($0.20) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.05. The company's revenue for the quarter was up 3.9% compared to the same quarter last year. What other stocks do shareholders of Cardiovascular Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiovascular Systems investors own include Meta Platforms (META), Netflix (NFLX), Advanced Micro Devices (AMD), Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA) and Home Depot (HD). Company Calendar Last Earnings2/08/2023Today7/28/2025Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CSII CIK1180145 Webwww.csi360.com Phone(651) 259-1600Fax612-677-3355Employees780Year Founded1989Profitability EPS (Trailing Twelve Months)($0.97) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$36.93 million Net Margins-15.79% Pretax Margin-15.73% Return on Equity-15.39% Return on Assets-11.93% Debt Debt-to-Equity Ratio0.08 Current Ratio6.04 Quick Ratio4.92 Sales & Book Value Annual Sales$239.84 million Price / Sales3.52 Cash FlowN/A Price / Cash FlowN/A Book Value$6.12 per share Price / Book3.27Miscellaneous Outstanding Shares42,198,000Free Float40,594,000Market Cap$843.96 million OptionableOptionable Beta0.74 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NASDAQ:CSII) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredIs America’s Everything Bubble About to Burst?On July 4th, Trump signed the “One Big Beautiful Bill,” adding $3.4 trillion to the national debt — and pushin...American Alternative | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTop 10 Green Zone Stocks to Buy NowOthers have paid $2,000 for access to stock picks like these—this weekend, you can get them free. Using a p...TradeSmith | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiovascular Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiovascular Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
